TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER
Clinical trials for TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER trials appear
Sign up with your email to follow new studies for TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can choosing your therapy style boost Psilocybin's power against depression?
Symptom relief Not yet recruitingThis study tests whether letting people with treatment-resistant depression choose between music-focused or mindfulness-focused therapy during psilocybin sessions improves results. Sixteen adults will receive two doses of psilocybin, each paired with a different therapy style. Th…
Matched conditions: TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Kyle Greenway • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC
-
Could ketamine and therapy curb suicidal thoughts in Tough-to-Treat patients?
Symptom relief Not yet recruitingThis study looks at whether a drug called ketamine, given through an IV, along with a type of talk therapy (DBT), can help reduce suicidal thoughts in people with borderline personality disorder and depression or bipolar disorder. About 120 adults will get either ketamine or a pl…
Matched conditions: TREATMENT-RESISTANT MAJOR DEPRESSIVE DISORDER
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Symptom relief
Last updated May 14, 2026 12:04 UTC